Home Newsfeeds Microsoft Official Says Co. Has More Than 1.4B Monthly Active Windows Devices

News

Microsoft Official Says Co. Has More Than 1.4B Monthly Active Windows Devices

-Reuters

byMichael Horton

February 7, 2023

1 minute read

-Reuters

Dayton Children’s Hospital Bridges Epic Hyperdrive Migration With PortalGuard IAM Cloud To Expand Its Utilization Of BIO-key Identity-Bound Biometrics

By Happy Mohamed

April 11, 8:08 AM

BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced that its

BKYI

Sagimet Biosciences Announces Completion Of Enrollment Of 120 Patients For Phase 3 Clinical Trial By Its Partner Ascletis Of Denifanstat Combined With Bevacizumab For Treatment Of Recurrent Glioblastoma

By Benzinga Newsdesk

September 27, 4:09 PM

Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced that its license partner, Ascletis Bioscience

SGMT

Evercore ISI Group Maintains Outperform on Equitable Holdings, Lowers Price Target to $41

By Benzinga Newsdesk

July 6, 9:46 AM

Evercore ISI Group analyst Thomas Gallagher maintains Equitable Holdings (NYSE:EQH) with a Outperform and lowers the price target from $45 to $41.

EQH

Facebook Ireland Guilty Of User Privacy Breach During 2010-2020, Dutch Court Finds

By Anusuya Lahiri

March 15, 1:47 PM

A Dutch court hearing a class action lawsuit on Wednesday held Meta Platforms, Inc's (NASDAQ: META) Facebook Ireland responsible for misusing the personal data of Dutch citizens from 2010 - 2020.

Microsoft Official Says Co. Has More Than 1.4B Monthly Active Windows Devices

Related Posts

Dayton Children’s Hospital Bridges Epic Hyperdrive Migration With PortalGuard IAM Cloud To Expand Its Utilization Of BIO-key Identity-Bound Biometrics

Sagimet Biosciences Announces Completion Of Enrollment Of 120 Patients For Phase 3 Clinical Trial By Its Partner Ascletis Of Denifanstat Combined With Bevacizumab For Treatment Of Recurrent Glioblastoma

Evercore ISI Group Maintains Outperform on Equitable Holdings, Lowers Price Target to $41

Facebook Ireland Guilty Of User Privacy Breach During 2010-2020, Dutch Court Finds